BRILINTA can lead to fewer CV events for STEMI patients compared to clopidogrel, allowing a growing support for BRILINTA® (ticagrelor) [package insert]. Find out about the BRILINTA® (ticagrelor) mechanism of action. BRILINTA is the first-and-only ;(3) BRILINTA® (ticagrelor) [package insert]. Patient Information Leaflet. Package leaflet: Information for the user. Brilique 90 mg film-coated tablets ticagrelor. Read all of this leaflet carefully before you start .
|Country:||United Arab Emirates|
|Published (Last):||10 September 2017|
|PDF File Size:||3.36 Mb|
|ePub File Size:||15.34 Mb|
|Price:||Free* [*Free Regsitration Required]|
The optimal duration of Plavix therapy is unknown.
After one year administer 60 mg twice daily. Bradyarrhythmias including AV block have been reported in the post-marketing setting. You may report side effects related to AstraZeneca products by clicking here. People who are treated with a stent, and stop taking BRILINTA too soon, have a higher risk of getting a blood clot in the pavkage, having a heart attack, or dying. Do not take new medicines that contain aspirin.
The benefit for patients who undergo primary percutaneous coronary intervention is unknown. Plavix is a registered trademark of sanofi-aventis. Strong inducers substantially reduce ticagrelor exposure and so decrease the efficacy of ticagrelor As with other oral P2Y 12 inhibitors, isnert of opioid agonists delay and reduce the absorption of ticagrelor.
BRILINTA® (ticagrelor) tablets | For Health Care Professionals
Plavix is indicated to reduce the rate of myocardial infarction and stroke For in patients with acute ST-elevation myocardial infarction STEMI who are to bfilinta managed medically. Instances of serious bleeding, such brilinya internal bleeding, may require blood transfusions or surgery. I recently had a heart attack, but I am not a victim.
Subject to eligibility rules ; restrictions apply. Plavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, packge infarction, or stroke.
Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not go away. Tell your doctor if you take other medicines that contain aspirin. Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
BRILINTA® (ticagrelor) tablets | Antiplatelet & Heart Attack Treatment
BRILINTA is used with aspirin to lower your chance of having another serious problem with your heart or blood vessels such as heart attack, stroke, or blood clots in your stent if bgilinta received one.
Strong inhibitors substantially increase ticagrelor exposure and so increase the risk of adverse events.
For at least the first 12 months following ACS, it is superior to clopidogrel. Your doctor can decide what treatment is needed. Administer 90 mg twice daily during the first year inserh an ACS event.
Plavix has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction MIor stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia. These can be brilint. For complete information on changes to the Plavix PI, go to www.
A CHANGING TREATMENT PARADIGM
Plavix should be administered in conjunction with aspirin. Bleeding will also take longer than usual to stop. You may report side effects related to AstraZeneca products by clicking here.